-

HealthTrust to Share Clinical Services Expertise at AHVAP 2023 Annual Conference

GRAPEVINE, Texas--(BUSINESS WIRE)--HealthTrust Performance GroupSM, a leading performance improvement company for healthcare, is excited to announce its participation in the Association of Healthcare Value Analysis Professionals (AHVAP) 2023 Annual Conference September 25-28 at the Gaylord Texan Resort & Convention Center in Grapevine, Texas.

Julie London, BSN, RN, Senior Director of Clinical Resource Management at HealthTrust will speak in a session titled, The True Value of Cross-Functional Collaboration: A Panel Discussion of Perspectives from Across the Healthcare Continuum along with other healthcare executives and clinical service leaders on September 26 from 4:15-5:15 p.m. In this panel, Julie and peers will discuss how the role of GPOs has evolved post-pandemic, and what makes it so beneficial to healthcare systems in the modern healthcare landscape.

HealthTrust is a Diamond Industry Partner sponsor of this year’s AHVAP Conference and will also have representatives at booth 500 in the exhibit hall.

The AHVAP 2023 Annual Conference is a top industry conference focused on healthcare value analysis. This conference convenes healthcare providers, group purchasing organizations, supplier partners, and others with the intention to share best practices, connect with peers and continue to advance the value analysis specialty.

About HealthTrust Performance Group

HealthTrust Performance Group (HealthTrust) is a provider owned and operated performance improvement organization committed to strengthening operational and clinical excellence through an aligned membership model and advisory services that leverage operator experience, scale, and innovation. Headquartered in Nashville, Tennessee, HealthTrust serves approximately 1,800 hospitals and health systems in the U.S. and the United Kingdom, and more than 65,000 non-acute locations including ambulatory surgery centers, physician practices, long-term care, and alternate care sites. HealthTrust has earned designation as a Top Workplace in Middle Tennessee.

Contacts

Richard Jonardi
richard.jonardi@healthtrustpg.com
615.344.3368

HealthTrust Performance Group


Release Summary
HealthTrust is excited to announce its participation in the AHVAP 2023 Annual Conference September 25-28.
Release Versions

Contacts

Richard Jonardi
richard.jonardi@healthtrustpg.com
615.344.3368

More News From HealthTrust Performance Group

HealthTrust Helps Lead Main-Stage Conversation at 2026 Healthcare Sessions

NASHVILLE, Tenn.--(BUSINESS WIRE)--HealthTrust Performance Group™ (HealthTrust) took the main stage at 2026 Healthcare Sessions, Sept. 13-15 in Nashville, Tenn., bringing clinical, operational and strategic viewpoints to conversations about how healthcare organizations can strengthen results amid rising complexity, persistent cost pressures and rapid technological change. Produced by the Nashville Health Care Council, Healthcare Sessions convenes leading healthcare decision-makers and change-ma...

HealthTrust Highlighted GPO Value and Growth Strategies at Fall 2026 IDN Summit

NASHVILLE, Tenn.--(BUSINESS WIRE)--HealthTrust Performance Group™ (HealthTrust) participated in the Fall 2026 IDN Summit and Reverse Expo, held Aug. 31-Sept. 2 at the JW Marriott Phoenix Desert Ridge Resort & Spa in Phoenix. The event brought together senior healthcare supply chain and pharmacy executives with solution providers for an in-person event featuring CE-accredited breakout sessions, visionary keynotes, senior-level idea exchanges and product-sourcing opportunities. HealthTrust ad...

HealthTrust Convenes Third Annual 340B Summit

NASHVILLE, Tenn.--(BUSINESS WIRE)--HealthTrust Performance Group™ (HealthTrust) hosted its third annual 340B Summit in Denver from July 22-23, 2026, to help members navigate the evolving 340B Drug Pricing Program, in its efforts to make healthcare missions possible. With increased compliance demands for covered entities, ongoing legal challenges and heightened scrutiny, HealthTrust members explored issues spanning legislation, drug pricing and operations that directly impact 340B program effect...
Back to Newsroom